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Osteoarthritis (OA) is a leading cause of disability, globally. Despite an emerging role for
synovial inflammation in OA pathogenesis, attempts to target inflammation therapeutically
have had limited success. A better understanding of the cellular and molecular processes
occurring in the OA synovium is needed to develop novel therapeutics. We investigated
macrophage phenotype and gene expression in synovial tissue of OA and inflammatory-
arthritis (IA) patients. Compared with IA, OA synovial tissue contained higher but variable
proportions of macrophages (P < 0.001). These macrophages exhibited an activated
phenotype, expressing folate receptor-2 and CD86, and displayed high phagocytic capacity.
RNA sequencing of synovial macrophages revealed 2 OA subgroups. Inflammatory-like OA
(iOA) macrophages are closely aligned to IA macrophages and are characterized by a cell
proliferation signature. In contrast, classical OA (cOA) macrophages display cartilage
remodeling features. Supporting these findings, when compared with cOA, iOA synovial
tissue contained higher proportions of macrophages (P < 0.01), expressing higher levels of
the proliferation marker Ki67 (P < 0.01). These data provide new insight into the
heterogeneity of OA synovial tissue and suggest distinct roles of macrophages in
pathogenesis. Our findings could lead to the stratification of OA patients for suitable
disease-modifying treatments and the identification of novel therapeutic targets.
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Introduction
Osteoarthritis (OA) is the most prevalent form of  arthritis and a leading cause of  disability in the Western 
world. Its incidence has doubled since the mid-20th century (1, 2). OA is characterized by the progres-
sive destruction of  cartilage, causing pain and disability. Attempts to develop disease-modifying drugs 
have so far failed, leaving joint replacement as the final therapeutic option (3). In 2015, >90,000 patients 
received a total knee replacement in the United Kingdom; this figure is expected to double over the next 
decade (4, 5). Although outcomes of  total joint replacement are positive for the majority, up to 20% are 
dissatisfied due to persistent pain or stiffness, which may be related to inflammation in the residual soft 
tissues (6, 7). There is, therefore, a requirement to improve our understanding of  OA pathogenesis in 
order to develop novel interventions.
The pathogenesis of  primary OA remains poorly understood, but it has become clear that inflammatory 
processes are involved. Synovial inflammation present in OA patients is usually low grade and does not lead 
to overt systemic inflammation (8). However, there is a clear positive correlation between synovial inflam-
mation and clinical features of  OA, such as pain, swelling, and cartilage damage (9–15). Recently, Soul et 
al. (16) suggested that OA patients are heterogeneous and could be stratified into 2 major patient subgroups 
based on the gene expression of  knee articular cartilage, showing altered patterns of  matrix protein gene 
expression (16). Indeed, clinical heterogeneity in OA pathogenesis is increasingly becoming recognized (17–
20). However, OA patients are not currently stratified for clinical trials based on synovitis or inflammatory 
biomarkers (21) because the mechanisms governing synovial inflammation in OA are not sufficiently under-
stood. Clinical trials with antiinflammatory treatments in OA have so far been disappointing, which may 
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reflect underlying OA disease heterogeneity (21, 22). Stratification of  OA patients based on inflammatory 
processes in the synovium may be helpful for matching the most appropriate antiinflammatory treatments 
to the individual OA patient.
Several lines of  evidence implicate macrophages in OA pathogenesis. Within the normal synovium, 
macrophages are the main immune cell type (23) and are most likely to be the front-line cells that sense 
joint damage. In response to damage-associated molecular patterns (DAMP) signals, macrophages in the 
OA synovium are reported to contribute to cartilage destruction and osteophyte formation by producing 
promatrix metalloproteinases (MMPs), and cytokines including IL-1β, TNF-α, and TGF-β (24–26). Histo-
logical studies have observed enhanced numbers of  macrophages in OA synovium (26–28), which correlat-
ed with the degree of  synovial angiogenesis (26), a hallmark of  synovitis. Recently, a noninvasive imaging 
study with a folate receptor-β–based agent has shown that the quantity of  activated macrophages in the 
knee of  OA patients correlated with disease severity and progression (29), implicating these cells in OA 
pathogenesis. Depletion of  macrophages in animal models of  OA can markedly reduce osteophyte forma-
tion (24, 25) but can also enhance synovial inflammation (30), suggesting diverse roles of  macrophages in 
OA pathogenesis. Indeed, macrophages are known to exert both proinflammatory and antiinflammatory/
tissue repair functions (31). Recent studies have revolutionized our understanding of  tissue macrophage 
heterogeneity, revealing how their diverse functions are modulated by the local tissue environment (31–33).
In order to design new therapeutic approaches that selectively target the pathogenic function of  syno-
vial macrophages, we first need to understand which of  their functions contribute to OA pathogenesis and 
how they interact with their environment. To address this aim, we have profiled gene expression by syno-
vial macrophages from OA and IA patients. These data reveal 2 distinct subgroups of  OA patients, one of  
which is characterized by macrophage proliferation.
Results
Identification and enumeration of  synovial tissue cell populations. We identified synovial macrophages and other 
immune cell subsets by flow cytometry (Figure 1A). Autofluorescence has previously been used as a marker 
of  tissue macrophages in skin (34, 35). Within the autofluorescent fraction, a putative HLA-DR+CD14+ 
synovial macrophage population was identified (T1). These expressed other markers of  macrophages (e.g., 
CD64 and CD11c) and morphological features including large size and abundant cytoplasm with multiple 
vacuoles (Figure 1B). In contrast, within the nonautofluorescent fraction, a population of  HLA-DR+ cells 
were likely to represent tissue monocytes (T3) and DCs (T4), as indicated by surface marker expression 
(CD11c, CD14 for monocytes; CD11c, CD1c for DCs) as well as their morphological appearance (Figure 
1, A and B). CD4+ T cells were identified within the CD3+ fraction (T2). Full surface marker phenotypes of  
synovial cell subsets are listed in Table 1.
Manual and computational approaches were employed to quantify the cellular distribution in the 
synovial tissue of  IA and OA patients (Figure 1, C–E). viSNE plots, based on the t-distributed stochastic 
neighbor embedding (tSNE) algorithm, were used to visualize representative cell contributions and rela-
tionships from high-dimensional flow cytometry data. Cell clusters were determined by protein expression 
of  CD45, HLA-DR, CD3, CD16, CD11c, CD14, CD4, and CD1c, as well as autofluorescence. Activated 
T cells were identified by expression of  HLA-DR. When comparing the cellular distribution in the synovi-
al tissue of  our IA and OA patient cohorts (OA, n = 64; IA, n = 19; Supplemental Table 1; supplemental 
material available online with this article; https://doi.org/10.1172/jci.insight.125325DS1), OA consisted 
of  fewer CD45+ cells (Supplemental Figure 1), with macrophages representing the main immune cell sub-
set (Figure 1, C–E). However, this proportion of  macrophages was highly variable between OA patients 
(Figure 1E). IA synovial tissue contained larger proportions of  CD4+ T cells, represented in blue by 
viSNE analyses (Figure 1D) and by manual quantification (Figure 1E). Furthermore, a proportion of  IA 
CD4+ T cells had an activated phenotype (Figure 1D), while activated CD4+ T cells could not be detected 
in OA synovial tissue. A significant difference was measured in BMI between OA and IA patient cohorts. 
To address whether BMI was inducing the infiltration of  macrophages into the synovium of  OA patients, 
we stratified the proportion of  macrophages, in addition to monocytes, DCs, and T cells identified by flow 
cytometry, with BMI. No significant differences were measured (data not shown).
Phenotype and functional assessment of  synovial macrophages. We next determined functional attributes and 
phenotype of  synovial macrophages. The ability of  macrophages to phagocytose fluorescent latex beads 
was measured by flow cytometry. Synovial macrophages displayed comparable phagocytic capacity to in 
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vitro blood CD14+ monocyte–derived macrophages, indicating that the tissue-extracted cells retained this 
function (Figure 2A). Moreover, synovial macrophages were more efficient at phagocytosis than in vitro 
CD14+ monocyte-derived DCs (Figure 2A) and synovial DCs (Figure 2B). To ensure that the beads were 
internalized, confocal microscopy was performed. Z-stack images were produced to allow visualization of  
the beads on the same field as the cell nucleus, in addition to high-contrast differential interference contrast 
microscopy (Figure 2, C and D). In addition to common macrophage markers HLA-DR, CD14, CD11c, 
and CD64, we found that synovial macrophages expressed CD86 and FOLR2 (Figure 2E). No significant 
difference was observed between OA and IA macrophages in the expression of  the cell surface markers 
measured (Figure 2E) or in cell size (data not shown).
RNA sequencing of  synovial tissue macrophages identifies 2 distinct OA subgroups. In order to identify any dif-
ferences between synovial macrophages from OA and IA, we performed RNA sequencing (RNA-Seq) on 
synovial macrophages isolated from OA and IA patients (OA, n = 9; IA, n = 3; Supplemental Table 2). To 
verify the purity of  macrophage samples sequenced, the expression of  a set of  macrophage genes and genes 
of  potential contaminating cell subsets were measured (Figure 3A). All samples lacked expression of  genes 
associated with other immune cell types, including B cells (B cell receptor; BCR, CD1c), DCs (CD1c), NK 
cells (nuclear adhesion molecule; NCAM1), stromal cells (THY1), and T cells (T cell receptor α constant; 
TRAC). Additional DC gene sets were measured to further confirm purity of  our HLA-DR+CD14+ syno-
vial macrophage population (Supplemental Figure 2). In contrast, all macrophage samples expressed genes 
associated with macrophages, including CD14, CD68, CSF1R, HLA-DRA, and MARCO. We evaluated the 
expression of  genes characteristic of  M1/M2 macrophages. However, we did not observe any clear correla-
tion with M1/M2 macrophage genes in our dataset (Supplemental Figure 3). When plotting the principal 
components of  these data, some clustering of  IA samples was evident, but OA samples appeared to be high-
ly diverse (Figure 3B). When plotting the top 500 most variable genes in a hierarchical heatmap, 2 distinct 
clusters are present: a group of  OA samples and a group of  OA and IA samples (Figure 3C). This differential 
clustering was still evident in the absence of  the IA samples and remained after considering only the top 25 
most variable genes (Supplemental Figure 4, A and B). In relation to the IA group, the distinct OA group 
was termed classical OA (cOA), whereas the OA subgroup that proved more similar to IA was designated 
inflammatory-like OA (iOA). Interestingly, these cOA and iOA groups correlate with the flow cytometry 
synovial tissue immune profiling data, giving further credence to our findings (Supplemental Figure 4C).
Gene expression pathway analysis suggests distinct disease mechanisms. Gene expression analysis revealed that 
155 genes were differentially expressed between the cOA and iOA subgroups (>1.5 fold change; P < 0.05, 
Benjamini-Hochberg multiple test corrected) (Figure 3D). Differential gene expression analysis between 
cOA vs. iOA and cOA vs. IA yielded the greatest number of  differentially expressed genes, compared with 
OA vs. IA and iOA vs. IA, further supporting the gene expression similarities observed between iOA and 
IA (Supplemental Figure 5 and Supplemental Tables 3–6). Gene set enrichment analysis (GSEA) of  the dif-
ferentially expressed gene set from cOA vs. IA showed numerous genes involved in cartilage development 
and extracellular organization (Supplemental Table 5). Particularly, SMAD3 is common to many of  these 
functional pathways. Indeed, SMAD3 has been previously identified in genome-wide association studies 
(GWAS) and is associated with OA (36, 37). In contrast, when investigating genes overexpressed in iOA 
as compared with cOA, a strong cell cycle signature was identified (Supplemental Table 6). In line with 
the cell cycle signature of  the iOA group, synovial tissue of  this group contained a significantly increased 
proportion of  synovial macrophages as compared with cOA synovial tissue (Figure 4B). After intersect-
ing the differentially expressed gene sets across each comparison, the majority of  upregulated genes were 
determined to be unique to each group (Figure 4A). However, nearly half  of  the downregulated genes 
Table 1. Full surface marker phenotype of cell subsets isolated from synovial tissue and peripheral blood
Cell population Surface marker phenotype
Macrophage (HLA-DR+CD14+) Live, CD19–, CD20–, CD45+, AF+, CD14+, HLA-DR+
T cell (CD4+) Live, CD19–, CD20–, CD45+, AF–, HLA-DR–, CD3+, CD14–, CD4+
Monocyte (CD14+) Live, CD19–, CD20–, CD45+, AF–, HLA-DR+, CD3–, CD16–, CD11c+, CD14+
DC (CD1c+) Live, CD19–, CD20–, CD45+, AF–, HLA-DR+, CD3–, CD16–, CD11c+, CD1c+
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were shared between the cOA vs. IA and cOA vs. iOA comparison, suggesting a commonly overexpressed 
pathway shared between iOA and IA, with the genes mapping to a proliferative signature. The proliferation 
marker Ki67–encoding gene MKI67 was highly overexpressed in iOA compared with cOA (7.2 log2 fold 
change; adjusted P = 0.013). Between cOA vs. IA and cOA vs. iOA, only 9 upregulated genes intersect 
against 103 exclusive genes, signifying a difference in regulation of  overexpressed genes. This is visualized 
in an UpSet plot ordered by frequency (Figure 4A).
To assess the link between increased numbers of  macrophages and cell cycle gene signatures in 
iOA, we measured the protein expression of  the proliferation marker Ki67 and assessed the frequency 
Figure 1. Characterization of synovial tissue cellular content in arthritis patients. Synovial tissue from OA total knee replacement and IA ultrasound 
guided biopsy was digested using optimized protocol. (A) Flow cytometry identification of synovial tissue HLA-DR+CD14+ macrophages (T1), CD4+ T cells 
(T2), CD14+ monocytes (T3), and DCs (T4). (B) Cytospin morphological assessment of synovial tissue cell subsets. Scale bar: 20 μm. Images are representa-
tive of 5 individual experiments. (C) tSNE analysis of flow cytometry data for OA synovial tissue mononuclear cells. Cell clusters were determined by both 
featurePlots and conventional flow cytometry gating on tSNE-analyzed FCS files; macrophage, T cell, monocyte, and DC clusters were determined, as indi-
cated in Table 1. (D) tSNE analysis of flow cytometry data for IA synovial tissue mononuclear cells. Cell clusters were determined by both featurePlots and 
conventional flow cytometry gating on tSNE-analyzed FCS files; macrophage, T cell, monocyte, and DC clusters were determined as indicated in Table 1;  
CD11clo cluster was determined by low expression of CD11c on HLA-DR+ population; activated CD4+ T cell cluster was determined by expression of HLA-DR 
by CD4+ T cells. (E) Enumeration of OA and IA synovial tissue cell subsets as a percentage of total CD45+ cells. T cell, n = 32; macrophage, n = 45; monocyte, 
n = 45; DC, n = 45. *P ≤ 0.05, ***P ≤ 0.001 by 2-tailed unpaired t test.
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of  macrophages in OA subgroups by flow cytometry (Figure 4, C–E). This demonstrated that those 
synovial tissue samples with large quantities of  macrophages (>30% of  CD45+ cells; Figure 4C) have a 
significantly higher proportion of  macrophages that stain positive for Ki67 (Figure 4, D and E), perhaps 
suggesting that the increased proportion of  synovial macrophages measured are directly contributed to 
by macrophage proliferation. Taken together, these data demonstrate that OA synovial macrophages 
have heterogeneous gene expression signatures that may represent differing cellular disease mecha-
nisms and/or contrasting disease tissue environments.
Discussion
Through the in-depth characterization of  synovial macrophages, we have been able to identify 2 distinct 
OA subgroups, cOA and iOA, which contain distinct macrophage populations with different functions. 
cOA macrophages were characterized by a tissue remodeling signature and were distinct from IA synovi-
al macrophages. In contrast, iOA macrophages displayed a strong proliferation signature and were more 
closely aligned with macrophages from IA synovial tissue. This was further validated by flow cytometry, 
which distinguished the same iOA and cOA subgroups by macrophage frequency, indicating that the 
different macrophage gene signatures are associated with a differential macrophage abundance and pro-
liferative characteristics. The expression of  proliferation marker Ki67 was significantly higher in synovial 
tissues that contained larger numbers of  macrophages, suggesting that the relative and absolute increase 
in macrophages in the iOA group is, at least in part, driven by cell division.
Figure 2. Synovial tissue macrophages. Synovial tissue from OA total knee replacement and IA ultrasound-guided biopsy was digested using optimized 
protocol. (A) Expression of latex bead fluorescence in FITC channel. Histograms depict OA synovial tissue macrophages incubated with beads (blue), cells 
incubated without beads (red), and beads alone (gray). Left panel depicts monocyte-derived DCs, middle panel depicts monocyte-derived macrophages, 
and right panel depicts OA synovial tissue macrophages. Data are representative of 3 independent experiments. mo, monocyte-derived. (B) Phagocytosis 
of latex beads by OA synovial tissue macrophages and DCs. n = 3. (C) Confocal microscope image utilizing differential interference contrast (DIC). Left pan-
el depicts OA synovial tissue macrophages cultured without latex beads. Right panel depicts OA synovial tissue macrophages cultured with latex beads. 
Images are representative of 3 individual experiments. Original magnification, 100×. (D) Confocal Z-stack reconstruction of 39 images of an OA synovial 
tissue macrophage. Blue areas indicate DAPI staining of nucleus. Green areas indicate latex beads. (E) Cell surface staining of CD86, CD64, and FOLR2 on 
synovial macrophages from OA (blue) and IA (red). FMO, gray. Data are representative of 4 experiments. **P ≤ 0.01 by 2-tailed unpaired t test.
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Macrophage proliferation and accumulation is usually seen under inflammatory conditions — for 
example, in response to infection with parasites (38) or in atherosclerotic plaques (39). Mouse model studies 
have furthermore shown that these proliferating macrophages are not derived from monocytes entering the 
inflamed tissue, but instead represent self-renewal of  resident macrophages (38, 39). Our finding that syno-
vial macrophages have a proliferation signature in a subset of  OA patients is the first demonstration to our 
knowledge that a similar process may be going on in the OA synovium. Since proliferation of  mouse tissue 
resident macrophages was driven by inflammation, our finding also strongly suggests that the proliferating 
macrophages signature identifies OA patients in whom synovial inflammation is part of  disease pathogenesis.
Historically, macrophages have been described as either proinflammatory (M1) or antiinflammatory 
(M2), defined on the basis of  monocyte responses to stimuli in vitro (40, 41). Our data indicate that synovial 
macrophages from OA or IA patients do not clearly align with this M1/M2 paradigm. Our findings are in 
line, however, with other studies investigating the function of  tissue macrophages (42). Indeed, it is now 
Figure 3. Identification of osteoarthritis synovial tissue macrophage heterogeneity. RNA sequencing of synovial macrophages and data analyses were 
conducted following description in methods. (A) Log counts per million (logCPM) expression levels of macrophage genes (left panel) and B cell (BCR), DC 
(CD1C), NK cell (NCAM1), stromal (THY1), and T cell (TRAC) genes (right panel). (B) PCA plot of all samples. Red text and circle identifies IA samples; blue 
text and triangle identifies OA samples. (C) Hierarchical clustering heatmap of top 500 genes across OA samples. (D) Volcano plot identifying significantly 
differentially expressed genes between cOA and iOA (>1.5-fold change; P < 0.05, Benjamini-Hochberg multiple test corrected), identified by blue data 
points. Red data points identify nondifferentially expressed genes.
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becoming accepted that M1 and M2 macrophages do not adequately reflect tissue macrophages in vivo; 
they are now regarded as polar extremes of  a spectrum of  in vitro macrophage activation states (43). Our 
RNA-Seq data shows that a mixture of  both M1- and M2-related genes can be expressed by synovial macro-
phages across all patients. This could either reflect the presence of  a mixture of  M1- and M2-like polarized 
macrophages in the arthritic synovial tissues or differential activation states of  these synovial macrophages 
within the 2 extremes of  the M1/M2 spectrum. Either way, the M1/M2 activation state of  the synovial 
macrophages does not appear to model the activation status of  ex vivo synovial macrophages in disease.
The transcriptomic analyses revealed a substantial heterogeneity within the OA synovial macrophage 
samples. This heterogeneity, and lack of  OA stratification, masked differences when performing differential 
gene expression analysis between IA and OA macrophages (3 genes were differentially expressed between the 
IA and OA subgroups [>1.5 fold change; P < 0.05, Benjamini-Hochberg multiple test corrected]; Supplemen-
tal Figure 5 and Supplemental Table 3). There has only been 1 previous study performing gene expression 
Figure 4. Functional gene set analysis of iOA and cOA. RNA sequencing of synovial macrophages and data analyses were conducted following description 
in methods. (A) UpSet plot visualizing the sets of differentially expressed genes from different contrasts, including the quantitative analysis of aggregate 
intersections between comparisons. Sets ordered by frequency. DEGs (>1.5-fold change; P < 0.05, multiple test corrected) identified in OA vs. IA, iOA vs. IA, 
and cOA vs. iOA. (B) Percentage of macrophages in CD45+ cell fraction of synovial tissue of RNA-sequenced samples. n = 8. (C) Cell subsets measured as a 
percentage of CD45+ cell fraction isolated from synovial tissue. cOA and iOA subgroups from additional samples identified initially by enumeration of synovi-
al macrophages. cOA ≤ 30% macrophages; iOA ≥ 30% macrophages. n = 6. (D) KI67+ macrophages in iOA group identified in C. Data are representative of 6 
individual experiments. (E) Enumeration of Ki67+ macrophages in cOA and iOA groups identified in C. n = 6. *P ≤ 0.05, **P ≤ 0.01 by 2-tailed unpaired t test.
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analysis on purified synovial macrophages from rheumatoid arthritis (RA) and OA patients (44). This recent 
paper also struggled to identify clear distinctions between RA and OA macrophage gene signatures and did 
not stratify OA patients. This failure to observe differences between RA and OA gene expression may be 
due to differences in flow cytometry/FACS sorting gating strategy; for example, if  autofluorescence is not 
included, DCs and monocytes may also be captured with macrophages (data not shown), thus contributing 
to heterogeneous gene expression profiles of  RNA-sequenced samples (44). These findings highlight that the 
classification of  OA as a single disease group may not be appropriate for this heterogeneous disease, as well as 
the importance of  using autofluorescence when identifying synovial macrophages.
Upon reclassifying OA samples into cOA and iOA, more differences were observed in differential gene 
expression between IA and cOA, as well as the 2 OA subgroups themselves, cOA vs. iOA. The observa-
tion of  similar clustering in a parallel dataset (i.e., flow cytometry enumeration of  immune cell subsets) 
supports our classification. Distinct functional gene signatures were further identified in cOA and iOA. 
cOA was defined by cartilage remodeling features, whereas iOA was characterized by a proliferation signa-
ture. Since IGFBP5 is associated with the negative regulation of  inflammatory mediators, overexpression 
of  this gene in cOA macrophages could indicate a less inflammatory tissue environment compared with 
IA. Likewise, overexpression of  HTRA1 is observed in cOA macrophages compared with IA. HTRA1 can 
modulate synovial fibroblasts to produce cartilage catabolic MMPs. Alongside the observed overexpression 
of  EFEMP1, potentially acting as a negative regulator of  chondrogenesis, this could demonstrate a poten-
tial mechanism of  cartilage destruction and subsequent failure of  cartilage repair in these cOA patients. 
SMAD3 was also observed to be overexpressed, and RUNX2 was observed to be underexpressed in cOA 
macrophages compared with both IA and iOA macrophages, again suggesting an additional failing tissue 
repair mechanism. The overexpression of  ULK1 in IA and iOA macrophages compared with cOA macro-
phages was also of  interest. It was noted that expression of  ULK1 was absent in cOA macrophages. ULK1 
is protective of  cartilage and could present another mechanism of  cartilage destruction through reduced 
autophagy and increased chondrocyte death (45).
iOA macrophages were more closely aligned to IA macrophages, and genes expressed had a strong 
association with cell cycle processes. The overexpression of  MKI67 in iOA macrophages compared with 
cOA macrophages was of  particular interest, since it encodes a well-associated protein of  cell proliferation, 
Ki67. Indeed, iOA synovial tissue contained higher proportions of  macrophages, and synovium samples 
with high proportions of  macrophages expressed high levels of  the protein Ki67. Additionally, E2F8 and 
CDT1, which also modulate cell proliferation thorough G1/S phase, were also overexpressed in iOA. As 
iOA macrophages were comparable in their gene expression profile to IA macrophages, this macrophage 
proliferation could be responding to an immune cell–driven inflammatory stromal interaction within the 
joint, as documented in IA (46). Overexpression of  CTRL in iOA macrophages compared with cOA macro-
phages may also reflect a more inflammatory environment and result in further contribution to this inflam-
matory environment, creating a positive feedback loop.
Interestingly, the iOA and cOA subgroups did not correlate with any of  the clinical data, including 
radiographic measures of  disease severity (Kellgren-Lawrence X-ray score), indicators of  systemic inflam-
mation (C-reactive protein [CRP] and erythrocyte sedimentation rate [ESR]), or medication. This suggests 
that the distinction of  2 OA groups based on their macrophage gene signature cannot be predicted and is 
most likely not influenced by these parameters. Although the small sample size may have precluded any cor-
relations between clinical data and the iOA and cOA groups (RNA-Seq cohort, n = 8), correlations were also 
not found when analyzing the proportion of  synovial macrophages (flow cytometry cohort, n = 64) and the 
clinical parameters. Thus, for future stratification of  OA patients for treatments targeting synovial inflamma-
tion, more specific biomarkers will need to be developed to indicate which subgroup OA patients belong to.
Taken together, these data suggest that there are divergent synovial tissue environments between cOA 
and iOA patients. It is likely that these environments specifically modulate synovial macrophages to differ-
ing patterns of  gene expression. iOA appears to be particularly inflammatory, whereas cOA pathogenesis 
is likely to be centered around cartilage degradation. Within cOA macrophages, there are aberrant tissue 
repair mechanisms, in addition to factors that may directly contribute to cartilage degradation. iOA mac-
rophages are highly proliferative, as reflected by their gene signature, their increased expression of  Ki67, 
and their enhanced proportions within the synovium, as measured by flow cytometry. It is likely that the 
synovial environment directly contributes to these macrophages’ proliferative capacity, but there is scope 
for a positive feedback loop whereby the macrophages further exacerbate synovial inflammation.
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The identification of  the iOA and cOA subgroups confirms the long-postulated heterogeneity between 
OA patients. Recognizing and understanding these OA subgroups will allow us to explore and understand 
the heterogeneity of  this disease. Ultimately, the stratification of  OA patients for suitable disease-modifying 
treatments could lead to a true personalized medicine approach, in addition to the identification of  novel 
therapeutic targets and biomarkers that can improve disease diagnosis and monitoring.
Methods
Cell isolation. Peripheral blood mononuclear cells (PBMCs) were isolated using density gradient centrifugation 
over Lymphoprep (Axis Shield). CD14+ monocytes were isolated using CD14 magnetic microbeads (Miltenyi 
Biotec) according to the manufacturer’s protocol. Synovial tissue was dissociated into 1-mm fragments. Liber-
ase TM (Roche Diagnostics) was added at a final concentration of  0.15 μg/ml and DNase (Roche Diagnos-
tics) at 0.30 μg/ml and incubated in a shaking incubator (260 rpm) at 37°C for 45 minutes, with additional 
vigorous shaking every 15 minutes. Solution was filtered with a 100-μm filter, and filtrate was immediately 
placed on ice to stop enzymatic digestion. Any remaining tissue was subjected to repeated digestion steps.
Generation of  monocyte-derived DCs and macrophages. CD14+ monocytes were cultured at 0.5 × 106 cells/ml 
in 24-well plates with 50 ng/ml IL-4 (Immunotools) and 50 ng/ml GM-CSF (Immunotools) for generation 
of  DCs, or 50 ng/ml MCSF (PeproTech) for generation of  macrophages. On day 3, cytokine supplemented 
medium was refreshed. On day 6, cells were harvested, washed, and used in functional assays. Cells were 
cultured in RPMI 1640 (MilliporeSigma), supplemented with 10% FBS (Thermo Fisher Scientific) and 2 
mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (all MilliporeSigma) at 37°C with 5% CO2.
Flow cytometry staining, cell sorting, and analysis. For cell surface staining, single cell suspensions were 
incubated in FACS buffer (PBS + 3% FBS (Life Technologies BRL) + 0.2% EDTA (Fisher Scientific) + 
0.1% sodium azide (Sigma-Aldrich)) + flow cytometry antibodies (Supplemental Table 7) + human IgG + 
viability dye. Flow cytometry and FACS sorting was performed on a BD Fortessa X20 or BD Aria FACS 
Fusion instrument, and data were analyzed using FlowJo10 (Tree Star Inc.). Flow cytometry gating strategy 
was based on fluorescence minus one (FMO), unstained, and isotype controls. For downstream applications 
involving cell culture, cells were sorted into cold culture medium. For genomic analysis, cells were sorted 
directly into RLT buffer (Qiagen) +1% β-Mercaptoethanol (MilliporeSigma), vortexed, and immediately 
frozen on dry ice. For intracellular staining, cells were fixed and permeabilized using eBioscience intracel-
lular fixation and permeabilization buffer set (eBioscience Intracellular Fixation & Permeabilization Buffer 
Set), according to manufacturer’s instructions. Cells were stained with Ki-67 antibody (Supplemental Table 
7). Cells were preincubated with 2% mouse and rat serum (both MilliporeSigma) prior to antibody labeling.
Phagocytosis assay and confocal microscopy imaging. Fluorescent latex beads (1 μm; MilliporeSigma, 
L4655) were added to cells at a 1/4000 dilution. Cells were incubated for 3 hours at 37°C. After incubation, 
cells were harvested and washed 3 times with PBS to ensure removal of  unbound beads or beads on the 
cell surface. Viability dye was added and bead uptake measured by flow cytometry. Slide preparations for 
confocal microscopy were carried out using CellTAK and mounted with Vectashield containing DAPI. 
Fluorescent latex beads (fluorescence excitation wavelengths [λex], ~470 nm; emission wavelength [λem], 
~505 nm) were imaged using Leica TCS SP8 confocal microscope, LAS X Software, and an EVOS FL Cell 
Imaging System (Invitrogen).
Cytospin and immunostaining. Cytospins were prepared by spinning FACS-purified cells onto cytospin 
slides at 600 g for 8 minutes using a cytocentrifuge (Shandon Cytospin 4; Thermo Fisher Scientific). Cyto-
spin slides were fixed in methanol prior to Giemsa-Wright staining performed using Advia S60 (Siemens) 
with Hematek Wright-Giemsa stain PAK. Imaging was carried out using Olympus CKX41 inverted phase 
contrast microscope and Olympus CAMEDIA C-7070 digital camera.
RNA-Seq. RNA was isolated from FACS purified peripheral blood and synovial tissue cells using QIA-
GEN Micro RNeasy kit. Quantification and quality control was carried out using high-sensitivity RNA 
screen tape (Agilent Technologies) on an Agilent 2200 Tapestation. Samples were diluted accordingly to 
normalized quantities of  RNA. Smart-seq v4 (Clontech) amplification was performed and Nextera XT 
DNA library prep kit was used. RNA-Seq was performed using Illumina NextSeq 500 at a 10 million, 75 bp 
read depth at the Genomics Core Facility (GCF) at Newcastle University led by Jonathan Coxhead. Qual-
ity control of  RNA-Seq was carried out with FastQC. Read trimming was performed with Trimmomatic, 
mapping, and alignment with STAR and quantification with HTSEQ. SeqMONK was run to account for 
any DNA contamination. Counts were filtered to remove those of  low number (<0.5 counts per million), 
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followed by assessment of  batch effect. All high-level analyses of  RNA-Seq data were performed with R. 
After voom normalization of  data, differential gene expression was performed using Limma, with an adjust-
ed P value threshold < 0.05 based on Benjamini-Hochberg correction and log fold change > 1.5. Exploratory 
Kyoto Encyclopaedia of  Genes and Genomes (KEGG) pathway analysis and Gene Ontology (GO) GSEA 
were performed on differentially expressed genes after correcting for RNA length. For synovial tissue cel-
lular characterization, 83 arthritis patients were collected (64 OA and 19 IA). For synovial tissue RNA-Seq 
analyses, 12 arthritis patients were collected (9 OA and 3 OA). Sample X1_OA was removed from further 
RNA-Seq analyses due to principal component analysis revealing that extrinsic influences unrelated to the 
biological conditions had skewed the data of  this sample. To quantify the suspected outlier, we examined 
the eigenvalue variation along the first principal component, which determined this outlier to be beyond 3 
SDs; this validates that this sample has likely been affected by processing or sequencing error and that the 
inclusion of  this sample in further analyses would prove uninformative.
Data and materials availability. RNA-Seq data are publicly available (GEO accession no. GSE123492).
Statistics. Statistical analyses were carried out in Prism 5.03 (GraphPad Software), Minitab 17 Statisti-
cal Software (Minitab Inc.), and R version 3.4.3. Replicates for all data in main figures ranged from n = 3 to 
n = 64 and are specified in figure legends. Students t tests performed were 2-tailed and unpaired. A P value 
of  less than 0.05 was considered significant. Data represent mean ± SEM.
Study approval. This study was conducted according to Declaration of  Helsinki principles. Healthy 
peripheral blood samples were obtained from volunteers with written informed consent under the New-
castle Autoimmune Inflammatory Rheumatic Diseases Research Biobank (NAIRD). Ethical approval was 
granted by the Newcastle and North Tyneside Research Ethics Committee (REC reference 12/NE/0395). 
OA arthritis synovial tissue from total knee replacement surgery was obtained with written informed con-
sent through the Newcastle Bone and Joint Study (NBJS). Ethical approval was granted by the Newcastle 
and North Tyneside Research Ethics Committee (REC reference number 09/H0906/72). IA wrist synovial 
tissue was obtained with written informed consent by ultrasound-guided needle biopsy from patients with 
RA or psoriatic arthritis attending the Newcastle Early Arthritis Clinic (NEAC) who were themselves naive 
to immunomodulatory treatment, including steroids. Ethical approval was granted by the Newcastle and 
North Tyneside Research Ethics committee (REC reference number 12/NE/0251).
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